Imaging of cardiac and renal perfusion in a rat model with 13N–NH3 micro-PET

International Journal of Cardiovascular Imaging

Volumn 31, Issue 1, 2015, Pages 213-219

  Juárez Orozco, Luis E ^a,b,c   Szymanski, Mariusz K ^a   Hillege, Hans L ^a   Kruizinga, Silvana ^a   Noordzij, Walter ^a   Koole, Michel ^a   Tio, René A ^a   Alexanderson, Erick ^b,c   Dierckx, Rudi A J O ^a   Slart, Riemer H J A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

13N ammonia; Cardiorenal; Perfusion; PET

Indexed keywords

AMMONIA N 13; AMMONIA; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORONARY ARTERY LIGATION; HEART EJECTION FRACTION; HEART INFARCTION; HEART PERFUSION; KIDNEY PERFUSION; MALE; NONHUMAN; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; RAT; SOLUTION AND SOLUBILITY; ANIMAL; CORONARY ARTERY BLOOD FLOW; DIAGNOSTIC USE; DISEASE MODEL; HEART MUSCLE; HEART STROKE VOLUME; KIDNEY CIRCULATION; MYOCARDIAL PERFUSION IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; SCINTISCANNING; WISTAR RAT;

AMMONIA; ANIMALS; CORONARY CIRCULATION; DISEASE MODELS, ANIMAL; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL PERFUSION IMAGING; MYOCARDIUM; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; RATS, WISTAR; RENAL CIRCULATION; STROKE VOLUME;

EID: 84922005456     PISSN: 15695794     EISSN: 15730743     Source Type: Journal    
DOI: 10.1007/s10554-014-0538-1     Document Type: Article

References (20)

1. Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de Zeeuw D, Charlesworth A et al (2000) Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2:203–210
2. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R (2008) Cardiorenal syndrome. J Am Coll Cardiol 19:1527–1539
3. Smilde TD, Damman K, van der Harst P, Navis G, Westenbrink BD, Voors AA et al (2009) Differential associations between renal function and “modifiable” risk factors in patients with chronic heart failure. Clin Res Cardiol 2:121–129
4. Kilcoyne MM, Schmidt DH, Cannon PJ (1973) Intrarenal blood flow in congestive heart failure. Circulation 4:786–797
5. Evans RG, Eppel GA, Anderson WP, Denton KM (2004) Mechanisms underlying the differential control of blood flow in the renal medulla and cortex. J Hypertens 8:1439–1451
6. Kudo T, Fukuchi K, Annala AJ, Chatziioannou AF, Allada V, Dahlbom M et al (2002) Noninvasive measurement of myocardial activity concentrations and perfusion defect sizes in rats with a new small-animal positron emission tomograph. Circulation 1:118–123
7. Tio RA, Dabeshlim A, Siebelink HM, de Sutter J, Hillege HL, Zeebregts CJ et al (2009) Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease. J Nucl Med 2:214–219
8. Nitzsche EU, Choi Y, Killion D, Hoh CK, Hawkins RA, Rosenthal JT et al (1993) Quantification and parametric imaging of renal cortical blood flow in vivo based on Patlak graphical analysis. Kidney Int 5:985–996
9. Killion D, Nitzsche E, Choi Y, Schelbert H, Rosenthal JT (1993) Positron emission tomography: a new method for determination of renal function. J Urol 3:1064–1068
10. Chen BC, Germano G, Huang SC, Hawkins RA, Hansen HW, Robert MJ et al (1992) A new noninvasive quantification of renal blood flow with N-13 ammonia, dynamic positron emission tomography, and a two-compartment model. J Am Soc Nephrol 6:1295–1306
11. Hillege HL (2012) Animal models of cardiorenal syndrome: a review. Heart Fail Rev 17(3):411–420
12. Westenbrink BD, Lipsic E, van der Meer P, van der Harst P, Oeseburg H, Du Marchie Sarvaas GJ et al (2007) Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization. Eur Heart J 16:2018–2027
13. Ulu N, Schoemaker RG, Henning RH, Buikema H, Teerlink T, Zijlstra FJ et al (2009) Proteinuria-associated endothelial dysfunction is strain dependent. Am J Nephrol 3:209–217
14. Van Kerckhoven R, van Veghel R, Saxena PR, Schoemaker RG (2004) Pharmacological therapy can increase capillary density in post-infarction remodeled rat hearts. Cardiovasc Res 3:620–629
15. Abassi Z, Gurbanov K, Rubinstein I, Better OS, Hoffman A, Winaver J (1998) Regulation of intrarenal blood flow in experimental heart failure: role of endothelin and nitric oxide. Am J Physiol 4(2):F766–F774
16. Ichikawa I, Pfeffer JM, Pfeffer MA, Hostetter TH, Brenner BM (1984) Role of angiotensin II in the altered renal function of congestive heart failure. Circ Res 5:669–675
17. Norman JT, Fine LG (2006) Intrarenal oxygenation in chronic renal failure. Clin Exp Pharmacol Physiol 10:989–996
18. 13N–NH3 micro-PET to examine left ventricular function in rats. Nucl Med Biol 39(5):724–726
19. Aukland K (1980) Methods for measuring renal blood flow: total flow and regional distribution. Annu Rev Physiol 42:543–555
20. Green MA, Hutchins GD (2011) Positron emission tomography (PET) assessment of renal perfusion. Semin Nephrol 3:291–299